Clinical Trials
4 trialsNCT02009449 2024-11-15
IVY
Eli Lilly and Company
Phase 1 Completed
NCT01183663 2016-06-03
Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)
M.D. Anderson Cancer Center
Phase 1 Completed
NCT00260611 2015-03-25
Study of Oxaliplatin and Taxotere in Prostate Cancer
University of Pittsburgh
Phase 2 Completed
NCT01338792 2014-03-10
Oxaliplatin and Pemetrexed Disodium in Treating Patients With Refractory Hormone-Resistant Prostate Cancer
University of Southern California
Phase 2 Completed